Three different polyhydroxyalkanoate (PHA) synthase genes (Ralstonia eutropha H16, Aeromonas sp. TSM81 or Aeromonas hydrophila ATCC7966 phaC) were introduced into the chromosome of two Pseudomonas strains: a native medium-chain-length 3-polyhydroxyalkanoate (PHAMCL) producer (Pseudomonas sp. LFM046) and a UV-induced mutant strain unable to produce PHA (Pseudomonas sp. LFM461). We reported for the first time the insertion of a chromosomal copy of phaC using the transposon system mini-Tn7. Stable antibiotic marker-free and plasmid-free recombinants were obtained. Subsequently, P(3HB-co-3HAMCL) was produced by these recombinants using glucose as the sole carbon source, without the need for co-substrates and under antibiotic-free conditions. A recombinant harboring A. hydrophila phaC produced a terpolyester composed of 84.2 mol% of 3-hydroxybutyrate, 6.3 mol% of 3-hydroxyhexanoate, and 9.5 mol% of 3-hydroxydecanoate from only glucose. Hence, we were successful in increasing the industrial potential of Pseudomonas sp. LFM461 strain by producing PHA copolymers containing 3HB and 3HAMCL using an unrelated carbon source, for the first time in a plasmid- and antibiotic-free bioprocess.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000495752 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Construction of antibiotic-free riboflavin producer in by metabolic engineering strategies with a plasmid stabilization system.
Synth Syst Biotechnol
June 2025
Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu 214122, China.
Riboflavin, an important vitamin utilized in pharmaceutical products and as a feed additive, is mainly produced by metabolically engineered bacterial fermentation. However, the reliance on antibiotics in the production process leads to increased costs and safety risks. To address these challenges, an antibiotic-free riboflavin producer was constructed using metabolic engineering approaches coupled with a novel plasmid stabilization system.
View Article and Find Full Text PDFConstruction and characterization of bioluminescent Reading outbreak and non-outbreak strains.
Microbiol Spectr
December 2024
Department of Poultry Science, Mississippi State University, Mississippi State, Mississippi, USA.
Unlabelled: enterica serotype Reading has recently been identified as a significant foodborne pathogen from contaminated poultry products. There is a critical need for close monitoring of this newly emerged pathogen. This study developed bioluminescent strains of Reading for real-time pathogen tracking using bioluminescence imaging.
View Article and Find Full Text PDFAntibiotic-Free High-Level l-Methionine Production in Engineered .
J Agric Food Chem
November 2024
The National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, P. R. China.
Article Synopsis
- l-Methionine is an important amino acid used in various industries, but its microbial production has challenges due to complex pathways and plasmid instability.
- Researchers enhanced the biosynthesis of l-methionine by improving nutrient supply and modifying metabolic pathways, resulting in a significant increase in production levels.
- The study successfully demonstrated antibiotic-free fermentation methods, enabling higher yields and stability in l-methionine production, with potential applications for other amino acids and chemicals.
Harnessing native-cryptic plasmids for stable overexpression of heterologous genes in Clostridium butyricum DSM 10702 for industrial and medical applications.
Microbiol Res
November 2024
The M-Lab, Department of Precision Medicine, GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht 6229 ER, the Netherlands.
Clostridium butyricum has emerged as a promising candidate for both industrial and medical biotechnologies, underscoring the key pursuit of stable gene overexpression in engineering C. butyricum. Unlike antibiotic-selective vectors, native-cryptic plasmids can be utilized for antibiotic-free expression systems in bacteria but have not been effectively exploited in C.
View Article and Find Full Text PDFArticle Synopsis
- Plasmid-based microbial systems are important for producing pharmaceuticals, but they usually need antibiotics for stability.
- Researchers created a new strain called A06Δ by relocating an essential gene and linking it with a specific enzyme on the same plasmid, aiming to remove the antibiotic requirement.
- The modified strain A17Δ outperformed A06Δ in producing phenylpyruvic acid (PPA), yielding 4.1 g L compared to 2.1 g L, and maintained plasmid stability for 10 transfers without antibiotics, eventually producing 18.7 g L of PPA in just 14 hours.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!